rs886037672
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_177438.3(DICER1):c.1525C>T(p.Arg509*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000684 in 1,461,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_177438.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461542Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727076
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
DICER1-related tumor predisposition Pathogenic:4
- -
ACMG criteria met: PVS1, PM2, PM7, PP4 -
This sequence change creates a premature translational stop signal (p.Arg509*) in the DICER1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DICER1 are known to be pathogenic (PMID: 19556464, 21266384). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with multinodular goiter (PMID: 23728841, 24839956, 26925222, 27459524). ClinVar contains an entry for this variant (Variation ID: 254288). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. -
PVS1, PS2, PS4, PM2_supporting, PP4 -
Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome Pathogenic:1
- -
Pleuropulmonary blastoma;C1867234:Rhabdomyosarcoma, embryonal, 2 Pathogenic:1
Null variant (nonsense) in gene DICER1, predicted to cause NMD. Loss-of-function is a known mechanism of disease. The exon contains 25 pathogenic variants. The truncated region contains 550 pathogenic variants (PVS1). Combined evidence strength is Very Strong (score = 9).Very Strong: ClinVar classifies this variant as Pathogenic, 2 stars associated with Global Developmental Delay - Lung Cysts - Overgrowth - Wilms Tumor Syndrome.Supporting: LOVD classifies this variant as Pathogenic (PP5). Variant not found in gnomAD genomes, good gnomAD genomes coverage = 31.0.GnomAD exomes allele count = 1 is less than 5 for AD gene DICER1 (PM2). 23-year-old female patient, with the presence of pancreatic cyst in childhood, pulmonary bullae and a high-grade fusocellular stromal neoplasm of the uterine cervix, compatible with embryonal rhabdomyosarcoma in adulthood. In addition, a heterozygous germline pathogenic variant of the DICER1 gene was identified. -
not provided Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.R509* pathogenic mutation (also known as c.1525C>T), located in coding exon 9 of the DICER1 gene, results from a C to T substitution at nucleotide position 1525. This changes the amino acid from an arginine to a stop codon within coding exon 9. This mutation has been observed in multiple individuals with a personal and/or family history that is consistent with DICER1-related disease (Darrat I et al. Head Neck, 2013 Dec;35:E369-71; de Kock L et al. Acta Neuropathol, 2014 Jul;128:111-22; Khan NE et al. Pediatr Nephrol, 2018 Dec;33:2281-2288; Dural O et al. J Pediatr Adolesc Gynecol, 2020 Apr;33:173-176). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at